Corvus Pharmaceuticals (CRVS) Earnings Date & Reports

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

CRVS is expected to report earnings to fall 10.23% to -11 cents per share on August 12

Corvus Pharmaceuticals CRVS Stock Earnings Reports

Q2'25

Est.

$-0.12

Q1'25

Missed

by $0.01

Q4'24

Missed

by $0.06

Q3'24

Missed

by $0.49

Q2'24

Beat

by $0.05

The last earnings report on May 08 showed earnings per share of -12 cents, missing the estimate of -11 cents. With 392.10K shares outstanding, the current market capitalization sits at 299.98M.

View a ticker or compare two or three

Compare

CRVS